Clinical trials
Phase 2 Anemia, Sickle Cell trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Shire | 2 |
| AstraZeneca | 1 |
| CSL Behring | 1 |
| Forma Therapeutics, Inc. | 1 |
| Hoffmann-La Roche | 1 |
| Modus Therapeutics AB | 1 |
| Novo Nordisk A/S | 1 |
| Sangart | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Sickle Cell | 12 |
| Iron Overload | 2 |
| Vaso-Occlusive Crises | 2 |
| beta-Thalassemia | 2 |
| Acute Chest Syndrome | 1 |
| Acute Kidney Injury | 1 |
| Albuminuria | 1 |
| COVID-19 | 1 |
| Hemoglobin SC Disease | 1 |
| Hemoglobinopathies | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.